Vicore Pharma Holding AB
VCRE | NASDAQ
$9.66
-$0.14 (-1.43%)
Nov 2, 2026, 11:05 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 578.15M |
Short-Term Investments | 588.59M |
Long-Term Investments | n/a |
Other Long-Term Assets | 1.71M |
Receivables | n/a |
Inventory | n/a |
Other Current Assets | 16.24M |
Total Current Assets | 1.22B |
Property-Plant & Equipment | n/a |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 1.71M |
Total Assets | 1.22B |
Account Payables | 39.47M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 78.9M |
Total Current Liabilities | 118.43M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 4.45M |
Total Long-Term Liabilities | 4.74M |
Total Liabilities | 123.18M |
Total Debt | n/a |
Book Value | 1.1B |
Book Value Per Share | 45.67 |
Common Stock | 140.76M |
Retained Earnings | -1.92B |
Comprehensive Income | n/a |
Shareholders Equity | 1.1B |
Total Investments | 588.59M |
Add to Watchlist
Select watchlists to add or remove VCRE